Deadly Drug-Resistant Fungus Candida Auris Spreads Across US

As the United States grapples with a severe flu season that has already claimed nearly 1,900 lives, health authorities are raising alarms over the rapid spread of another serious public health threat. A deadly, drug-resistant fungal infection, Candida auris, is expanding across the country, adding pressure to an already strained healthcare system.

Rising Infections Across Multiple States

According to data from the “Centers for Disease Control and Prevention”, Candida auris has infected at least 7,000 people across 27 US states so far. Health officials warn that the fungus spreads easily, particularly in healthcare settings, and poses a high risk to patients with compromised immunity or prolonged hospitalisation.

What Is Candida Auris?

Candida auris is a type of yeast that can cause severe illness. As per the CDC, it can lead to infections ranging from superficial skin involvement to life-threatening conditions such as bloodstream infections. The fungus is especially concerning because it can survive on surfaces for long periods and spread between patients in hospitals and long-term care facilities.

Why the Fungus Is Considered Dangerous

A key concern with Candida auris is its resistance to multiple antifungal medications. Drug resistance allows the organism to survive standard treatments, making infections extremely difficult, and in some cases impossible, to treat. This resistance significantly increases the risk of complications and mortality among vulnerable patients.

Imporatnt Facts for Exams

• Candida auris is a multidrug-resistant fungal pathogen.
• It primarily spreads in healthcare settings.
• The CDC monitors and reports fungal outbreaks in the US.
• Drug resistance makes Candida auris infections hard to treat.

Symptoms, Risk Factors and Prevention

Symptoms of Candida auris infection vary depending on the site of infection and may include fever or chills that do not improve with standard treatment. There is no single symptom specific to the fungus. Those most at risk include patients with serious underlying conditions and those using invasive medical devices such as ventilators, feeding tubes and catheters. The CDC advises strict infection-control measures, including frequent hand hygiene with alcohol-based sanitiser, isolation of infected or colonised patients, and regular cleaning of rooms with specialised disinfectants to prevent further spread.